Fatal reactivation of hepatitis B virus mutant following cytotoxic treatment
โ Scribed by Jean-Charles Duclos-Vallee; Pierre Laurent-Puig; Marie-Anne Loriot; Catherine Buffet; David Malka; Gilles Pelletier; Patrick Marcellin; Serge Erlinger; Jean-Pierre Etienne
- Book ID
- 118566478
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 105 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat
## BACKGROUND. A point mutation from G to A at nucleotide (nt) 1896 of the precore region of hepatitis B virus (HBV) DNA has been shown to be associated with fulminant and severe hepatitis. Further studies have suggested that this point mutation, together with additional mutations in the precore p